Last Updated on January 8, 2024 by The Health Master
Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of forty seven (47) formulations under the Drugs (Prices Control) Order, 2013, based on the decision of the Authority meeting held on based on the decision of 93rd Authority meeting dated 15.11.2021 vide notification S.O. 4884(E) dated 26-11-2021.
NPPA, in its order on November, 26, listed the forty seven (47) formulations for which it has fixed retail prices. List of the formulations has been given below
Formulations:
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Telmisartan + Chlorthalidone Tablet | Each uncoated bilayered tablet contains: Telmisartan IP 80.mg Chlorthalidone IP 6.25mg | 1 Tablet | M/s Windlas Biotech Pvt. Ltd. /M/s Mankind Pharma Ltd. | 16.27 |
| 2. | Cefixime Tablets | Each film coated tablet contains: Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 100mg | 1 Tablet | M/s. Hema Laboratories Pvt. Ltd. / M/s Softdeal Pharmaceuticals Pvt. Ltd. | 5.99 |
| 3. | Tacrolimus Ointment 0.1% w/w | Each gm of Ointment contains: Tacrolimus IP 1mg | 1 gram | M/s Helios Pharmaceuticals / M/s Panacea Biotec Pharma Limited | 35.44 |
| 4. | Tacrolimus Ointment 0.03% w/w | Each gm of Ointment contains: Tacrolimus IP 0.3mg | 1 gram | M/s Helios Pharmaceuticals / M/s Panacea Biotec PharmaLimited | 16.41 |
| 5. | Etoricoxib + Paracetamol Tablet | Each film coated tablet contains Etoricoxib IP 60 mg Paracetamol IP 325 mg | 1 Tablet | M/s Acme Lifetech LLP. / M/s Troikaa Pharmaceuticals Ltd. | 5.50 |
| 6. | Telmisartan + Chlorthalidone + Metoprolol (As Extended release form) Tablet | Each film-coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.5mg, Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as Extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd. | 10.88 |
| 7. | Telmisartan + Chlorthalidone + Metoprolol (As Extended release form) Tablet | Each film-coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.5mg, Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as Extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd. | 12.91 |
| 8. | Calcium + Cholecalciferol Tablets | Each film-coated tablet contains: Calcium (In the form of Calcium hydroxide and Calcium oxide pretreated with heated algae) 500mg Cholecalciferol IP 2000IU, | 1 Tablets | M/s USV Private Limited. | 12.64 |
| 9. | Cilnidipine, Telmisartan & Chlorthalidone Tablets | Each Film Coated Tablet contains: Cilnidipine IP 10mg Telmisartan IP 40mg Chlorthalidone IP 6.25mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Dr. Reddy’s Laboratories Ltd. | 11.61 |
| 10. | Paracetamol bilayered Tablet 1000mg | Each uncoated bilayered tablet contains: Paracetamol IP 300mg (as Immediate release) Paracetamol IP 700mg (as sustained release) | 1 Tablet | M/s. Sterling Lab | 2.90 |
| 11. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Eris Lifesciences Limited | 9.86 |
| 12. | Glimepiride + Metformin Hydrochloride (as Prolonged release form) Tablet | Each uncoated bilayered tablet contains: Glimepiride IP 2mg, Metformin Hydrochloride IP 500mg (as Prolonged release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. /M/s J. B. Chemicals & Pharmcaeuticals Ltd. | 9.41 |
| 13. | Telmisartan, Chlorthalidone & Amlodipine Tablet | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. /M/s Mankind Pharma Ltd. | 8.92 |
| 14. | Telmisartan, Chlorthalidone & Amlodipine Tablet | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. /M/s Mankind Pharma Ltd. | 9.95 |
| 15. | Chlorthalidone + Telmisartan Tablet | Each film coated Tablet contains: Chlorthalidone IP 6.25mg Telmisartan 40mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited | 8.60 |
| 16. | Metoprolol Tartrate + Ivabradine Tablet | Each film coated tablet contains: Metoprolol Tartrate IP 25mg Ivabradine Hydrochloride eq. to Ivabradine 5mg | 1 Tablet | M/s. Ajanta Pharma Limited | 15.46 |
| 17. | Metoprolol Tartrate + Ivabradine Tablet | Each film coated tablet contains: Metoprolol Tartrate IP 50mg Ivabradine Hydrochloride eq. to Ivabradine 5mg | 1 Tablet | M/s. Ajanta Pharma Limited | 17.74 |
| 18. | Lignocaine Hydrochloride, Chlorhexidine Gluconate & Metronnidazole Gel | Gel contains: Lignocaine Hydrochloride IP 2.0%w/w, Chlorhexidine Gluconate IP 1% w/w, Metronnidazole 1% IP w/w | 1 Gram | M/s Curetech Skincare / M/s J.B.Chemicals & Pharmaceuticals Ltd. | 3.48 |
| 19. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Eris Lifesciences Limited | 10.88 |
| 20. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Eris Lifesciences Limited | 10.81 |
| 21. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Eris Lifesciences Limited | 12.91 |
| 22. | Azelnidipine + Telmisartan Tablet | Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 40mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Ipca Laboratories Limited | 11.37 |
| 23. | Azelnidipine + Telmisartan Tablet | Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 80mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Ipca Laboratories Limited | 13.27 |
| 24. | Rosuvastatin + Clopidogrel Capsule | Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / Cadila Pharmaceuticals Ltd. | 19.64 |
| 25. | Rosuvastatin + Aspirin Capsule | Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg (As Pellets) Aspirin IP 75mg (As enteric coated Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / Cadila Pharmaceuticals Ltd. | 5.99 |
| 26. | Telmisartan + Amlodipine Tablet | Each Uncoated bilayered Tablet Contains: Telmisartan IP 40mg Amlodipine Besilate IP eq. Amlodipine 5mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s J.B.Chemicals & Pharmaceuticals Ltd. | 9.51 |
| 27. | Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablet | Each film coated tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartarate 25 mg (as Extended Release form) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s J.B.Chemicals & Pharmaceuticals Ltd. | 10.68 |
| 28. | Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablet | Each film coated tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartarate 50 mg (as Extended Release form) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s J.B.Chemicals & Pharmaceuticals Ltd. | 12.95 |
| 29. | Glimepiride + Metformin Hydrochloride (as Prolonged release form) Tablet | Each uncoated bilayered tablet contains: Glimepiride IP 1mg, Metformin Hydrochloride IP 500mg (as Prolonged release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. /M/s J. B. Chemicals & Pharmcaeuticals Ltd. | 6.72 |
| 30. | Atorvastatin + Aspirin Capsule | Each hard Gelatin Capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As Film Coated Tablet Form) Aspirin IP 75mg (As Enteric Coated Tablet Form) | 1 Capsule | M/s Pure & Cure Healthcare Pvt. Ltd. /M/s J. B. Chemicals & Pharmcaeuticals Ltd. | 2.68 |
| 31. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s IPCA Laboratories Limited | 9.86 |
| 32. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s IPCA Laboratories Limited | 10.88 |
| 33. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s IPCA Laboratories Limited | 10.81 |
| 34. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s IPCA Laboratories Limited | 12.91 |
| 35. | Escitalopram Oxalate + Clonazepam Tablet | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5mg, Clonazepam IP 0.5mg | 1 Tablet | M/s Windlas Biotech Limited / M/s Mankind Pharma Ltd. | 7.81 |
| 36. | Escitalopram Oxalate + Clonazepam Tablet | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 10mg, Clonazepam IP 0.25mg | 1 Tablet | M/s Windlas Biotech Limited / M/s Mankind Pharma Ltd. | 9.56 |
| 37. | Escitalopram Oxalate + Clonazepam Tablet | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 20mg Clonazepam IP 0.5mg | 1 Tablet | M/s Micro Labs Limited | 19.92 |
| 38. | Escitalopram Oxalate + Clonazepam Tablet | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5mg Clonazepam IP 0.5mg | 1 Tablet | M/s Micro Labs Limited | 7.90 |
| 39. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Intas Pharmaceuticals Limited | 12.91 |
| 40. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Intas Pharmaceuticals Limited | 10.88 |
| 41. | Cilnidipine, Telmisartan & Chlorthalidone Tablets | Each Film Coated Tablet contains: Cilnidipine IP 10mg Telmisartan IP 40mg Chlorthalidone IP 12.5mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / Dr. Reddy’s Laboratories Ltd. | 12.946 |
| 42. | Formoterol Fumarate + Budesonide Powder for Inhalation | Each hard gelatin capsule contains: Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 12mcg Budesonide IP 400mcg | 1 Capsule | M/s Biodeal Pharmaceuticals Pvt. Ltd./ M/s Mankind Pharma Limited | 7.10 |
| 43. | Omeprazole (Delayed-Release) + Domperidone (Sustained Release) Capsule | Each hard gelatin capsule contains: Omeprazole IP 20mg (as enteric coated pallets) Domperidone IP 30mg (as sustained release pallets) | 1 Capsule | M/s. Eris Lifesciences Ltd. / M/s Eris Healthcare Pvt. Ltd. | 8.53 |
| 44. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Torrent Pharmaceuticals Limited | 12.91 |
| 45. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 10.88 |
| 46. | Hydroxychloroquine Tablet | Each film coated tablet contains: Hydroxychloroquine Sulphate IP 300 mg | 1 Tablet | M/s Ravenbhel Biotech /M/s Torrent Pharmaceuticals Limited | 12.55 |
| 47. | Beclomethasone Dipropionate + Clotrimazole Cream base | Gram Contains: Beclomethasone Dipropionate IP 0.025% w/w, Clotrimazole IP 1.0%w/w, | 1 Gram | M/s Curetech Skincare / M/s J. B. Chemicals & Pharmaceuticals Ltd. | 5.20 |
(a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e.
the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Latest notifications – DPCO /NPPA
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021
NPPA fixes retail price of 23 formulations: September 2021
NPPA fixes retail price of 1 formulation: September 2021
NPPA extends ceiling price regulation on Orthopaedic knee implants
NPPA extends price cap on LMO and Oxygen inhalation
NPPA panel recommends 15% rise in ceiling price for 3 formulations
WHO issues these guidelines regarding Omicron
SII seeks DCGI’s nod for Covishield as booster dose
Govt’s guidelines: National Medical Commission Act 2019
USFDA approves new drug to help identify cancer lesions
Govt amends Drugs Rules on Import Licence and registration certificate
Govt is considering revising the DPCO to encourage drug innovation
Govt may impose anti-dumping duty on Pharma API from China
Govt is considering revising the DPCO to encourage drug innovation
6 arrested for Codeine cough syrup smuggling to Bangladesh
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
